Stock Ratings / Health Care / IMCC / dividends

AKAN (54) NAII (34) BON (45) MTEX (33) ⌘ Pro Terminal →

IM Cannabis Corp. (IMCC) Dividend Safety Gauge & 10-Year DRIP Compounder

Q: Is IMCC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, IM Cannabis Corp. (NASDAQ: IMCC) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 64/100 at a spot price of $0.91 (+3.53% 1D, market cap $1.5M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, IMCC ranks #148 in composite RQD confidence.

Q: How does IMCC compare to AKAN and NAII in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), IMCC carries a Roarable C (64/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, AKAN (Akanda Corp.) holds a D+ grade (54/100 RQD, P/E N/A, ROIC —, cap $2.6M) and NAII (Natural Alternatives International Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -10.8%, cap $6.9M). Among the 5-stock peer group, IMCC leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for IMCC?

For IM Cannabis Corp. (IMCC), key quantitative strengths include Big institutional funds and options desks are actively positioning on the bullish side. and sector rank #148 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is IMCC trading relative to its 50-day, 200-day, and 52-week technical levels?

IMCC last traded at $0.91 (+3.53% on volume of 23,467 shares), positioning the stock -57.08% below its 50-day simple moving average ($2.12) and -91.85% below its 200-day simple moving average ($11.16). Across its 52-week range of $0.76 to $62.40, IMCC sits at the 0.2% percentile with a 14-day RSI of 31.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $1.02).

Q: Does IMCC pay a dividend and is it safe?

IM Cannabis Corp. (IMCC) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

$0.91 +3.53% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.91

IM Cannabis Corp. (IMCC) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 64/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.1% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $1.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.91 (+0.45%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 64/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.1% avg 90D alpha vs SPY • 55.2% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C- · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+2.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for IMCC)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (64/100 Composite)

🔍 WHY IMCC SCORES 64/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (23% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+15/20 pts (23% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 31.1 (OVERSOLD (<32))

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$1.58-12% Next Q

Q2 (-2Q)

Grade B-$1.39-36.7% Next Q

Q3 (-1Q)

Grade B-$0.88+3.4% Next Q

Current

Grade C$0.91+1.1% Hist 90D α

Trajectory: B (72) → C (64)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the IMCC Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 64/100 (C) score, IMCC faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($2.12) or 200D SMA ($11.16) invalidates the momentum regime and cuts Target Base ($0.93) toward Bear Floor ($0.73).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $IMCC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “IMCC Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 64%NO 36%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $19,307

Est. Year-10 Shareholder Yield: $348/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.7K

Yr 1

$11.4K

Yr 2

$12.2K

Yr 3

$13.0K

Yr 4

$13.9K

Yr 5

$14.8K

Yr 6

$15.8K

Yr 7

$16.9K

Yr 8

$18.1K

Yr 9

$19.3K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in IMCC & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on IMCC and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

IMCC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -89.28%🛡️ HOLDING TREND SUPPORT

2026-10-30O $0.85H $0.91L $0.76C $0.91VOL 27.4K

RES: $8.24SUP: $0.27SMA50: $2.12SMA200: $11.16

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

IMCC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 IMCC Butterfly Map → + Track IMCC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on IMCC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for IMCC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for IMCC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IMCC)

Health Care Rank #148 of 1016 ⚔️ AKAN vs IMCC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (IMCC vs. AKAN, NAII, BON, MTEX)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, IM Cannabis Corp. (IMCC) ranks #148 by composite RQD confidence (64/100, grade C) and #1009 by equity capitalization ($1.5M). Within this direct 5-issuer industry benchmark cohort, IMCC leads on earnings valuation at N/A trailing P/E, while NAII leads on capital efficiency and profitability with -10.8% ROIC and 7.2% gross margin. IMCC currently leads its immediate peer cohort in composite quantitative strength at 64/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
IMCC ACTIVE IM Cannabis Corp.	C	64/100	—	—	—	+3.53%	$1.5M	Benchmark Subject
AKAN Akanda Corp.	D+	54/100	—	—	—	+2.80%	$2.6M	/akan-vs-imcc →
NAII Natural Alternatives International Inc.	E	34/100	—	7.2%	-10.8%	-4.31%	$6.9M	/naii-vs-imcc →
BON Bon Natural Life Limited (Class A)	D	45/100	—	20.8%	—	-0.01%	$9.2M	/bon-vs-imcc →
MTEX Mannatech Incorporated	E	33/100	—	74.9%	-35.0%	-2.23%	$16.1M	/mtex-vs-imcc →

2. IMCC Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

IM Cannabis Corp. (IMCC) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $1.5M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. IMCC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is IMCC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, IM Cannabis Corp. (NASDAQ: IMCC) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 64/100 at a spot price of $0.91 (+3.53% 1D, market cap $1.5M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, IMCC ranks #148 in composite RQD confidence.

How does IMCC compare to AKAN and NAII in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), IMCC carries a Roarable C (64/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, AKAN (Akanda Corp.) holds a D+ grade (54/100 RQD, P/E N/A, ROIC —, cap $2.6M) and NAII (Natural Alternatives International Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -10.8%, cap $6.9M). Among the 5-stock peer group, IMCC leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for IMCC?

For IM Cannabis Corp. (IMCC), key quantitative strengths include Big institutional funds and options desks are actively positioning on the bullish side. and sector rank #148 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Where is IMCC trading relative to its 50-day, 200-day, and 52-week technical levels?

IMCC last traded at $0.91 (+3.53% on volume of 23,467 shares), positioning the stock -57.08% below its 50-day simple moving average ($2.12) and -91.85% below its 200-day simple moving average ($11.16). Across its 52-week range of $0.76 to $62.40, IMCC sits at the 0.2% percentile with a 14-day RSI of 31.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $1.02).

IMCC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does IMCC pay a dividend and is it safe?

IM Cannabis Corp. (IMCC) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: IMCC RQD Cockpit IMCC 12M Forecast IMCC Earnings & Move IMCC Dividends & DRIP IMCC Insiders & 13F IMCC Whale Options IMCC Profit Sankey IMCC News & Why